EMBECTA CORP. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
EMBECTA CORP. (EMBC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 3.30M shares, a 23.26% decline year-over-year.
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.10M shares, a 5.13% increase year-over-year.
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-12-31 was 2.00M shares, a 33.33% decline year-over-year.
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 4.30M shares, a 0.00% change year-over-year.
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.30M shares, a 17.86% decline from fiscal 2024.
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.80M shares, a 55.56% increase from fiscal 2023.
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.80M shares, a 0.00% change from fiscal 2022.
- EMBECTA CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.80M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.30M shares 10-Q · filed 2026-08-07 | 1.30M shares 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | 4.10M shares 10-Q · filed 2026-05-05 | 1.80M shares 10-Q · filed 2026-05-05 | ||
| 2025-12-31 | 2.00M shares 10-Q · filed 2026-02-05 | |||
| 2025-09-30 | 2.30M shares 10-K · filed 2025-11-25 | |||
| 2025-06-30 | 4.30M shares 10-Q · filed 2026-08-07 | 2.50M shares 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | 3.90M shares 10-Q · filed 2026-05-05 | 2.50M shares 10-Q · filed 2026-05-05 | ||
| 2024-12-31 | 3.00M shares 10-Q · filed 2026-02-05 | |||
| 2024-09-30 | 2.80M shares 10-K · filed 2025-11-25 | |||
| 2024-06-30 | 4.30M shares 10-Q · filed 2025-08-08 | 2.80M shares 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | 4.20M shares 10-Q · filed 2025-05-09 | 2.80M shares 10-Q · filed 2025-05-09 | ||
| 2023-12-31 | 3.20M shares 10-Q · filed 2025-02-06 | |||
| 2023-09-30 | 1.80M shares 10-K · filed 2025-11-25 | |||
| 2023-06-30 | 2.10M shares 10-Q · filed 2024-08-09 | 1.90M shares 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | 2.20M shares 10-Q · filed 2024-05-09 | 1.80M shares 10-Q · filed 2024-05-09 | ||
| 2022-12-31 | 2.00M shares 10-Q · filed 2024-02-09 | |||
| 2022-09-30 | 1.80M shares 10-K · filed 2024-12-11 | |||
| 2022-06-30 | 1.80M shares 10-Q · filed 2023-08-08 | 1.80M shares 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |